Teva settles whistleblower lawsuit for $54M

Maia Anderson - Print  | 

Teva Pharmaceuticals agreed Jan. 6 to pay $54 million to settle a lawsuit claiming the drugmaker illegally paid physicians to boost prescriptions for two of its drugs, according to the Philadelphia Business Journal

The lawsuit, filed in 2013, claimed Teva persuaded physicians to write prescriptions for the drugs Copaxone, a multiple sclerosis treatment, and Azilect, a Parkinson's drug, by paying them as speakers or consultants. Many of the speaker programs were allegedly sham events.

The lawsuit claimed Teva's actions violated the False Claims Act and the Anti-Kickback Statute, which prohibit drugmakers from compensating physicians in any way to persuade them to prescribe their drugs. 

A spokesperson for Teva told the Philadelphia Business Journal the drugmaker had no comment on the settlement. 

Read the full article here

More articles on pharmacy:
Walgreens secures enterprisewide specialty accreditation
Drug price hike update: Merck, Allergen, Novartis raise prices
Regeneron restructures, cuts at least 15 jobs

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.